Oncology News

ESMO oncology news ensures that you're always kept up to date with the latest developments that affect you and your daily practice. Make sure you check these pages frequently, or sign up to our newsletter.

Filter

Date Title Topic
10 Oct 2016 ESMO 2016: ERBB2 Gene Alterations May Be Prognostic of Poorer Outcome in Stage III Colon Cancer Translational research - Gastrointestinal cancers
10 Oct 2016 ESMO 2016: Results of the First Cohort of Patients Screened Within the New EORTC Molecular Platform for Patients With Colorectal Cancer Translational research - Gastrointestinal cancers
10 Oct 2016 ESMO 2016 Press Release: Single-Arm Trials Improve Early Access to Rare Cancer Drugs Translational research
10 Oct 2016 ESMO 2016 Press Release: Financial Difficulties Linked to Worse Outcomes From Cancer Treatment Bioethics, legal and economic issues
10 Oct 2016 ESMO 2016 Press Release: Cabozantinib Improves Progression-free Survival in Metastatic Renal Cell Carcinoma Genitourinary cancers
10 Oct 2016 ESMO 2016 Press Release: MEK Inhibition in KRAS-mutant NSCLC Did Not Improve Survival Lung and other thoracic tumours
10 Oct 2016 ESMO 2016 Press Release: Significant Survival Gains from Neoadjuvant Chemotherapy for High-risk Soft Tissue Sarcoma Sarcomas
10 Oct 2016 ESMO 2016 Press Release: Custirsen Shows no Survival Benefits in Metastatic Prostate Cancer Genitourinary cancers
10 Oct 2016 ESMO 2016 Press Release: First Feasibility Study of the ESMO-MCBS Scale in Rare Tumour Entities Bioethics, legal and economic issues
09 Oct 2016 ESMO 2016: Vemurafenib Shows Clinical Benefit in Diverse BRAF V600-Mutated Tumours Personalised medicine - Anticancer agents & Biologic therapy
09 Oct 2016 ESMO 2016: Triple Combination of Dabrafenib, Trametinib, and Panitumumab Improves Efficacy in BRAF Mutation Positive mCRC Gastrointestinal cancers - Anticancer agents & Biologic therapy
09 Oct 2016 ESMO 2016: Lenvatinib Shows Promising Activity in Patients with RET-Positive Adenocarcinoma of the Lung Lung and other thoracic tumours - Anticancer agents & Biologic therapy
09 Oct 2016 ESMO 2016: A Longer Interval Between Preoperative Chemoradiotherapy and Surgery Urged in Locally Advanced Rectal Cancer Gastrointestinal cancers
09 Oct 2016 ESMO 2016: Comprehensive Genomic Profiling Identifies Potentially Actionable Mutations in Small Bowel Adenocarcinoma Translational research - Gastrointestinal cancers
09 Oct 2016 ESMO 2016 Press Release: Greater Patient Selection May be Needed for First Line Nivolumab to Improve Progression-free Survival in Advanced Lung Cancer Lung and other thoracic tumours